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A 70-year-old man was admitted with complaint of gross hematuria. Cystoscopy and computed
tomography (CT) revealed a 2.5 cm nodular tumor in the urinary bladder. Pathological diagnosis after the
transurethral resection of bladder tumor (TURBT) was invasive urothelial cancer with trophoblastic
differentiation of pT1. The tumor was positively stained with human chorionic gonadotropin (HCG).
The serum HCG level was 12.8 IU/l in the fourth week after TURBT, and it increased to 35.7 IU/l in the
20th week after TURBT. However, radiological examination at this point did not reveal tumor recurrence
or metastases. Three months later, the patient coughed up bloody sputum. Lung metastases (up to 2.4
cm) were identiﬁed, and they were surgically removed. The pathological specimen consisted of
syncytiotrophoblastic giant cells with hemorrhage and necrosis, but no urothelial cancer element. Because
the lung and lymph node metastases developed soon after surgery, chemotherapy was planned. Because the
patient had impaired renal function with a creatinine clearance of 33.7 ml/min, we selected combination
chemotherapy with gemcitabine and oxaliplatin (GEMOX) rather than cisplatin -based chemotherapy. CT
after two courses of GEMOX showed stable disease, but HCG levels markedly decreased from 1,240 IU/l to
7.9 IU/l. This marker of response continued through six courses of GEMOX. Then, the chemotherapy
was discontinued due to grade 2 neuropathy. He died of cancer 12 months after development of metastases.
Autopsy revealed only tumor cells with trophoblastic differentiation, but no urothelial carcinoma in multiple
metastatic sites.
(Hinyokika Kiyo 64 : 55-61, 2018 DOI : 10.14989/ActaUrolJap_64_2_55)













患 者 : 70歳，男性




現病歴 : 2010年 4月，肉眼的血尿，排尿時痛を主訴
に当科受診．CT にて，左腎サンゴ状結石および膀胱
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Fig. 1. Plain CT showed a 25 mm nodular tumor
on the right wall of the bladder.
腫瘍を認めた（Fig. 1）．膀胱鏡では右側壁から後壁に





血算・生化学 : WBC 3,600/μl，RBC 445万/μl，Hb
13.8 g/dl，PLT 12.4万/μl，UA 7.8 mg/dl，BUN 17.8
mg/dl，CRE 1.7 mg/dl，LDH 179 U/I，ALP 344 U/I，
Na 140 mmol/l，K 4.5 mmol/l，Cl 108 mmol/l，CRP
0.31 mg/dl．
尿沈渣 : RBC 50∼99/hpf，WBC ＞100/hpf，蛋白
2＋
















これらを踏まえ TURBT の29日後に測定した HCG は
12.8 IU/l（基準値 4.9 IU/l 未満）であった．同年11
月，2nd TUR を施行したが，病理所見では癌の残存
を認めなかった．その後，HCG は 21.5 IU/l（2010年
12月），35.7 IU/l（2011年 1月）とさらなる上昇を認
めたが，膀胱鏡および尿細胞診にて局所再発を認め








胸部 CT にて左肺 S4 に約 1.6 cm および S9 に約 0.6
cm の腫瘍を認めた．気管支鏡下生検および細胞診に
て確定診断が得られず切除術の方針となった．術前
CT にて肺腫瘍は左 S4 が 2.4 cm，S9 が 1.0 cm と急
速増大を認め（Fig. 3），HCG は 177 IU/l まで上昇し








5週後，HCG は 803 IU/l とさらに上昇し，右肺転移
および左肺門部リンパ節転移が新出した．
化学療法の方針としたが，腎機能を評価したとこ








GEMOX 療法は 3 週サイクルでゲムシタビン 1,000
mg/m2 を第 1 日および第 8 日，オキサリプラチン
130 mg/m2 を第 1 日に経静脈投与するレジメンであ
る．
2011年 6月から GEMOX を施行したところ開始時
1,240 IU/l だった HCG が 2 コース終了時には 7.9
IU/l と著明に低下した．CT でも肺転移巣は径 15
mm から 8 mm，リンパ節転移は径 19 mm から 17 mm
に縮小し，RECIST では SD（27％縮小）と判定し
た．GEMOX の有害事象は骨髄抑制が主で 1コース
目に好中球減少 G4 および血小板減少 G4 を認めたた
め， 2コース目からゲムシタビン投与量を80％に減量
した．一方で腎機能の増悪は認めなかった．GEMOX
4コース後には HCG は 2.2 IU/l まで低下した．し
かしながら GEMOX 5コース目から感覚性の末梢神
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Fig. 2. Pathology of bladder tumor. A) Histopathological examination showed a mixture of high-grade (G3)
urothelial carcinoma (green arrow) and syncytiotrophoblastic giant cells (orange arrow) (×40). B) High-
grade urothelial carcinoma (HE × 400). C) Syncytiotrophoblastic giant cells (HE × 400). D, E) Im-
munohistochemical staining showed human chorionic gonadotropin (HCG)-positive for syncytiotrophoblastic
giant cells (×40) (×400).
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Fig. 3. Chest CT showed lung metastases.
泌62,08,0◆-4
Fig. 4. Pathology of lung metastases. The majority of the tumor cells consist of syncytiotrophoblastic giant
cells with hemorrhage and necrosis, and in most of the tumor cells HCG-positive in immunohistology.
A) HE ×40. B) HE ×200. C) HCG ×200.




GEMOX 終了時の HCG は 3.3 IU/l，画像効果判定は
SD であった．以降，外来にて経過観察したが，HCG
は 2週後に 10.6 IU/l と上昇に転じた．2012年 2月，
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Table 1. Cases of chemotherapy for urothelial carcinoma with trophoblastic differentiation with metastases









Obe 82 M Lung Radiotherapy 5-ﬂuorouracil PD Unknown Died ofcancer 1 Mo
Dennis 67 M Lung TUR,radiotherapy
Methotrexate Unknown Unknown Died of
cancer 2 MoBleomycin, vinblastine,
cisplatinum PD Unknown
Masui 57 M Lung Cystectomy


















Cystectomy BEP PD Unknown Died ofcancer 3 Mo





山下 75 M Lung Cystectomy EP SD Decrease Died ofcancer 3 Mo












TUR GC PD Increase Died ofcancer 6 Mo
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